Showing results (91-100 of 106) with videos related to
Sort By:
Pageof 11
The Pediatric Infectious Disease Journal|May 30, 2006
Lack of association of cervical lymphadenopathy and coronary artery complications in Kawasaki diseaseRita Y T Sung, Yin-Ming Ng, Kai-Chow Choi, et al.Environmental and Molecular Mutagenesis|June 26, 2001
Gender difference in DNA adduct levels among nonsmoking lung cancer patientsY W Cheng, L L Hsieh, P P Lin, et al.Cancer Research|April 18, 2001
The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese womenY W Cheng, H L Chiou, G T Sheu, et al.Oncogene|October 8, 2013
Phosphorylation of paxillin confers cisplatin resistance in non-small cell lung cancer via activating ERK-mediated Bcl-2 expressionD-W Wu, T-C Wu, J-Y Wu, et al.Biochimica Et Biophysica Acta|May 9, 2001
Cinnamophilin as a novel antiperoxidative cytoprotectant and free radical scavengerG Hsiao, C M Teng, J R Sheu, et al.Molecular Genetics and Metabolism|October 13, 2014
Phenotypic heterogeneity in monogenic diabetes: the clinical and diagnostic utility of a gene panel-based next-generation sequencing approachG Alkorta-Aranburu, D Carmody, Y W Cheng, et al.Oncogene|July 8, 2014
FHIT loss confers cisplatin resistance in lung cancer via the AKT/NF-κB/Slug-mediated PUMA reductionD-W Wu, M-C Lee, N-Y Hsu, et al.Oncogene|July 17, 2015
FHIT loss confers cisplatin resistance in lung cancer via the AKT/NF-κB/Slug-mediated PUMA reductionD-W Wu, M-C Lee, N-Y Hsu, et al.Oncogene|July 18, 2017
FHIT loss confers cisplatin resistance in lung cancer via the AKT/NF-κB/Slug-mediated PUMA reductionD-W Wu, M-C Lee, N-Y Hsu, et al.Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|June 19, 2013
The prognostic significance of APC gene mutation and miR-21 expression in advanced-stage colorectal cancerT-H Chen, S-W Chang, C-C Huang, et al.Pageof 11